Caremark Prior Authorization for Zepbound: UR Guide

Getting a Zepbound prior authorization approved through Caremark comes down to three things: confirming the plan's coverage criteria, submitting the exact documentation Caremark's reviewers look for, and knowing your appeal paths before a denial lands. This guide walks through each step, then shows how to reuse the same workflow discipline you already apply to behavioral health levels of care.

What is a prior authorization and why do GLP-1 drugs require one?

Prior authorization means the payor reviews a prescriber's request before covering a drug, and care cannot start until they approve it. Zepbound (tirzepatide) sits on CVS Caremark's formulary list with PA requirements attached, so a request without the right documentation is denied before a human clinician ever discusses medical necessity. GLP-1 drugs trigger this step because they are high-cost, high-volume, and prescribed for conditions with defined clinical criteria, like a BMI threshold plus a comorbidity. The payor wants proof the patient meets those criteria and that cheaper options were tried first. If you run UR at a behavioral health facility, the structure is familiar: criteria, documentation, deadline, appeal path. The same discipline you apply to ASAM level-of-care reviews is what a Zepbound PA demands, as we covered in prior authorization and behavioral health billing.

What does Caremark before approving Zepbound?

Caremark applies its standard GLP-1 prior authorization criteria: the patient must meet BMI thresholds, have tried and failed a covered step-therapy agent, and the prescriber must document medical necessity against the formulary policy. If any element is missing, the PA is rejected before clinical review even starts.

BMI and comorbidity thresholds

Caremark policies typically require a BMI of 30 or higher, or 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia. Confirm the exact thresholds against the patient's specific plan, since formulary placement and criteria vary by employer group and plan year.

Step therapy requirements

Most Caremark plans require documented trial and failure of at least one preferred weight-loss agent, usually a 90-day trial, before Zepbound is considered. Table:

The structure is familiar to UR staff: thresholds, step requirements, documentation, and an authorization window to track. Tools like CriteriaIQ surface these criteria inside your existing workflow in Kipu (https://criteriaiq.com/kipu-emr-authorization/), the same way they do for behavioral health levels of care.

What documentation should your prescriber submit for a Zepbound PA?

Documentation checklist

Caremark's service request form is only as strong as the clinical packet behind it. Your prescriber should assemble: the completed form with NPI, tax ID, and drug details (Zepbound, tirzepatide, dose, quantity, days supply); a chart note documenting the BMI or weight-related comorbidity that meets the label; prior weight-loss attempts with dates and outcomes; and any comorbidity diagnoses (sleep apnea, T2DM, hypertension) with supporting labs or sleep studies. The FDA prescribing information for Zepbound (tirzepatide) confirms the approved indications and BMI thresholds your packet must match (Prescribing Information).

Think of this the way you already think about a concurrent review packet. A UR nurse assembling medical necessity for a residential level of care pulls ASAM dimensions, physician orders, and assessments into one submission so the payor reviewer never has to call back for a missing piece. The Zepbound PA is the same discipline in miniature: one service request form, one complete clinical packet, submitted once. If you build the checklist as a template in Kipu or a shared doc, the prescriber's staff fills gaps before submission instead of after a denial. The same logic applies to matching documented criteria to the payor's own medical policy, which we break down further in ASAM criteria and insurance authorization.

Common gaps that trigger denials

The recurring CARC codes on these denials trace to three gaps: BMI documented but no comorbidity or weight history supporting medical necessity, prior treatment attempts listed without dates or outcomes, and a chart note that never states the diagnosis the form claims. Ask the prescriber's office to attach the actual labs and notes, not summaries of them, before the request goes out the door.

How long does a Caremark prior authorization for Zepbound take?

Standard vs expedited review

A standard Caremark PA decision is typically due within 72 hours of a complete request; expedited review, used when the prescriber certifies that waiting could jeopardize health, targets 24 hours. Submit through the Caremark provider portal or fax and confirm receipt the same day, because the clock starts at a complete submission, not the first contact. If your office hasn't received a determination by the deadline, call the provider line with the reference number ready.

When to escalate a stalled request

If the authorization window stalls, ask the payor rep for the specific missing item, get the call reference number, and set a follow-up date before hanging up. A request sitting in "pending information" past the 72-hour mark is a denial risk, not a queue. Track every stalled case in one place rather than a shared inbox; CriteriaIQ RCM flags authorization timelines across payors so nothing expires unnoticed, and our authorizations walkthrough shows the escalation steps your UR team can reuse for any payor.

What happens if your Zepbound prior authorization is denied?

Caremark sends a denial letter stating the reason, the clinical rationale, and your appeal rights. Standard determinations must arrive within 72 hours and expedited ones within 24 hours under Medicare Advantage organization determination rules, and commercial plans mirror similar turnaround requirements. Denials are not final; they start an appeal clock.

Common denial reasons

The recurring ones: missing BMI or comorbidity documentation, no trial of a preferred GLP-1 or lifestyle intervention, weight criteria not met, or the drug excluded from the formulary entirely. The letter usually shows a CARC code, such as 96 (non-covered) or 50 (not medically necessary), sometimes with a RARC explaining the gap. Log the code and the stated rationale the same way you log a medical necessity denial on a concurrent review.

Reading the denial letter

Match each CARC/RARC to the specific requirement Caremark says you missed. If the fix is a missing note or lab value, a corrected resubmission is faster than an appeal. For clinical disagreement, go straight to peer-to-peer. Steven Cavan covers how CriteriaIQ structures that documentation trail.

How do you appeal a Caremark denial for Zepbound?

A Caremark denial is not final. You can work it through internal appeal levels, request a peer-to-peer, or escalate to external review, much like a medical necessity denial on a residential stay.

Internal appeal levels

Caremark typically allows at least one internal appeal, sometimes more depending on the plan. File within the appeal window stated in the denial letter, and resubmit with something new: updated weight or comorbidity documentation, a corrected service request form, or a prior therapy history the first submission lacked.

Peer-to-peer review

Request a peer-to-peer between the prescriber and a Caremark medical director. This mirrors the P2P you already run for concurrent reviews: a clinician-to-clinician conversation where medical necessity criteria are argued directly. Prepare your prescriber with the specific denial reason and the plan criteria cited, so the call stays on the missing elements rather than restating the whole case.

External review

If internal appeals exhaust, most plans allow external review by an independent reviewer, whose decision binds the plan. Deadlines are strict, often 60 days or less from the final internal denial, so calendar it like an authorization window.

One honest caveat: external review outcomes are unpredictable, and a weak first submission is the most common reason appeals stall. Treat the initial PA the way you treat a first concurrent review packet, complete the first time.

When does a Zepbound prior authorization need to be renewed?

Caremark approvals for Zepbound are time-limited, typically 3 to 12 months depending on the plan, so track the authorization window the same way you track a residential stay's concurrent review dates. Missing the renewal deadline means a fresh PA from scratch, not a continuation.

At renewal, Caremark usually asks for documentation showing the member is still on the drug and still meeting criteria: current BMI or comorbidity status, adherence evidence (refill history), and notes confirming continued weight-loss progress or maintenance rationale. If the prescriber's chart is thin on any of these, request the note before submitting, because a renewal can be denied for the same missing-documentation reasons that trigger initial denials, often coded with CARC or RARC codes that tell you exactly what the payer says is absent (X12 CARC/RARC code lists).

How can UR teams reuse this workflow for behavioral health prior authorization?

The Zepbound process is the same discipline you already run for residential, PHP, and IOP authorizations: know the payor's criteria before the service request form goes out, submit complete documentation the first time, track the authorization window, and prepare the appeal file before the denial letter arrives. Apply that checklist to every level-of-care request and every medication PA, including step-downs.

Tracking authorization windows across payors

Each payor runs its own clock on concurrent review intervals and reauthorization deadlines. Log the authorization window, the next review date, and the assigned reviewer for every case at the moment the approval comes in, not the day before it lapses. Set reminders at least five business days ahead of each deadline so a delayed assessment never triggers an automatic denial.

Where manual tracking breaks down

Spreadsheets and shared inboxes work until one UR nurse covers two facilities, or a P2P call happens while someone is out. A single missing note then costs hours of rework. Tools like Ritten and Behave Health offer dedicated tracking, and Kipu Health and Sunwave Health cover adjacent workflows. Our own product, CriteriaIQ RCM, builds the checklist and timeline tracking directly on Kipu or BestNotes, though it does not replace your clinical judgment on medical necessity. Whichever system you use, the rule holds: one source of truth for every authorization window beats any spreadsheet.

FAQ

What's prior authorization for medication versus concurrent review?

Prior authorization happens before care starts: the payor reviews the prescriber's request and won't cover the drug until it approves. Concurrent review happens during an active authorization, where the payor rechecks that the patient still meets criteria for the ongoing service. A Zepbound PA is front-end; residential stay reviews are mid-treatment checkpoints on the same discipline.

What documentation gaps most often cause a Zepbound denial?

Three gaps recur: BMI documented without a comorbidity or weight history supporting medical necessity, prior treatment attempts listed without dates or outcomes, and a chart note that never states the diagnosis the form claims. Attach the actual labs and notes rather than summaries, and verify the packet against the plan's policy before the request leaves the prescriber's office.

How long does a Zepbound approval last before renewal?

Approvals are time-limited, typically 3 to 12 months depending on the plan. Renewal requires evidence the member is still on the drug and still meeting criteria: current BMI or comorbidity status, refill history showing adherence, and notes confirming continued progress. Missing the window forces a fresh PA from scratch, so track the deadline like any authorization window.